Literature DB >> 2201025

Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein.

R L Shoeman1, B Höner, T J Stoller, C Kesselmeier, M C Miedel, P Traub, M C Graves.   

Abstract

The intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein are cleaved in vitro by human immunodeficiency virus type 1 protease (HIV-1 PR). Microsequencing showed that HIV-1 PR cleaved both human and murine vimentin between leucine-422 and arginine-423 within the sequence between positions 418 and 427, Ser-Ser-Leu-Asn-Leu/Arg-Glu-Thr-Asn-Leu (SSLNL/RETNL). Minor cleavages at other sites were also observed. Heat-denatured vimentin was cleaved by HIV-1 PR less efficiently than native vimentin. A decapeptide containing the sequence SSLN-LRETNL was also cleaved in vitro by HIV-1 PR as predicted. The presence of a charged residue (arginine) at the primary cleavage site distinguishes this from other known naturally occurring cleavage sites. Microinjection of HIV-1 PR into cultured human fibroblasts resulted in a 9-fold increase in the percentage of cells with an altered and abnormal distribution of vimentin intermediate filaments. Most commonly, the intermediate filaments collapsed into a clump with a juxtanuclear localization. These results support the possibility that intermediate filament proteins may serve as substrates within HIV-1-infected cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201025      PMCID: PMC54528          DOI: 10.1073/pnas.87.16.6336

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Intermediate filaments: known structure, unknown function.

Authors:  H Bloemendal; F R Pieper
Journal:  Biochim Biophys Acta       Date:  1989-04-12

2.  Protein-chemical identification of the major cleavage sites of the Ca2+ proteinase on murine vimentin, the mesenchymal intermediate filament protein.

Authors:  S Fischer; J Vandekerckhove; C Ampe; P Traub; K Weber
Journal:  Biol Chem Hoppe Seyler       Date:  1986-11

3.  Coding sequence and growth regulation of the human vimentin gene.

Authors:  S Ferrari; R Battini; L Kaczmarek; S Rittling; B Calabretta; J K de Riel; V Philiponis; J F Wei; R Baserga
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

4.  Measurement of molecular weights by electrophoresis on SDS-acrylamide gel.

Authors:  K Weber; J R Pringle; M Osborn
Journal:  Methods Enzymol       Date:  1972       Impact factor: 1.600

Review 5.  Are intermediate filament proteins involved in gene expression?

Authors:  P Traub
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

6.  A gas-liquid solid phase peptide and protein sequenator.

Authors:  R M Hewick; M W Hunkapiller; L E Hood; W J Dreyer
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

7.  A rapid method for the large scale purification of the intermediate filament protein vimentin by single-stranded DNA-cellulose affinity chromatography.

Authors:  W J Nelson; C E Vorgias; P Traub
Journal:  Biochem Biophys Res Commun       Date:  1982-06-30       Impact factor: 3.575

8.  Isolation, purification and characterization of the intermediate filament protein desmin from porcine smooth muscle.

Authors:  C E Vorgias; P Traub
Journal:  Prep Biochem       Date:  1983

9.  Human immunodeficiency virus can productively infect cultured human glial cells.

Authors:  C Cheng-Mayer; J T Rutka; M L Rosenblum; T McHugh; D P Stites; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  Isolation of glial fibrillary acidic protein from bovine brain white matter and its purification by affinity chromatography on single-stranded DNA-cellulose.

Authors:  C E Vorgias; P Traub
Journal:  Biochem Biophys Res Commun       Date:  1983-08-30       Impact factor: 3.575

View more
  44 in total

1.  HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation.

Authors:  I Ventoso; R Blanco; C Perales; L Carrasco
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

2.  Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.

Authors:  A H Kaplan; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

3.  The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells.

Authors:  P H Chen; D A Ornelles; T Shenk
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

4.  Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation.

Authors:  H G Kräusslich
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

5.  Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein.

Authors:  T Wilk; B Gowen; S D Fuller
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  Cellular Vimentin Interacts with Foot-and-Mouth Disease Virus Nonstructural Protein 3A and Negatively Modulates Viral Replication.

Authors:  Xueqing Ma; Ying Ling; Pinghua Li; Pu Sun; Yimei Cao; Xingwen Bai; Kun Li; Yuanfang Fu; Jing Zhang; Dong Li; Huifang Bao; Yingli Chen; Zhiyong Li; Yonggang Wang; Zengjun Lu; Zaixin Liu
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

7.  Proteomic profiling of HIV-infected T-cells by SWATH mass spectrometry.

Authors:  Jason DeBoer; Melinda S Wojtkiewicz; Nicole Haverland; Yan Li; Emma Harwood; Emily Leshen; Joseph W George; Pawel Ciborowski; Michael Belshan
Journal:  Virology       Date:  2018-03       Impact factor: 3.616

8.  An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity.

Authors:  J Konvalinka; M A Litterst; R Welker; H Kottler; F Rippmann; A M Heuser; H G Kräusslich
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease.

Authors:  Dirk Jochmans; Maria Anders; Inge Keuleers; Liesbeth Smeulders; Hans-Georg Kräusslich; Günter Kraus; Barbara Müller
Journal:  Retrovirology       Date:  2010-10-15       Impact factor: 4.602

10.  Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta.

Authors:  C Tornatore; A Nath; K Amemiya; E O Major
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.